herO holds a commanding edge in this best-of-five PvT series thanks to his dominant recent form and overwhelming historical advantage against Cure. The Protoss star has won 16 of their last 18 encounters since the 5.0.14 balance patch, capitalizing on superior multitasking and map control to neutralize Terran aggression. Cure enters on strong overall momentum from the 2025 GSL season but has shown persistent vulnerabilities in direct matchups, where herO repeatedly disrupts build orders and transitions. With the current GSL map pool favoring Protoss early-game flexibility, traders see herO’s experience in high-stakes series as the decisive factor, though Cure’s strategic adaptability keeps a narrow path to an upset open.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertThis market will resolve to "Cure" if Cure win the match against herO.
This market will resolve to "herO" if herO win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Markt eröffnet: May 7, 2026, 12:00 PM ET
Abwicklungsquelle
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...This market will resolve to "Cure" if Cure win the match against herO.
This market will resolve to "herO" if herO win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Markt eröffnet: May 7, 2026, 12:00 PM ET
Abwicklungsquelle
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...herO holds a commanding edge in this best-of-five PvT series thanks to his dominant recent form and overwhelming historical advantage against Cure. The Protoss star has won 16 of their last 18 encounters since the 5.0.14 balance patch, capitalizing on superior multitasking and map control to neutralize Terran aggression. Cure enters on strong overall momentum from the 2025 GSL season but has shown persistent vulnerabilities in direct matchups, where herO repeatedly disrupts build orders and transitions. With the current GSL map pool favoring Protoss early-game flexibility, traders see herO’s experience in high-stakes series as the decisive factor, though Cure’s strategic adaptability keeps a narrow path to an upset open.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen